Prostate Cancer (PCa) is similar to breast cancer in that the cancer is dangerous once it metastasizes. By saying this I do not mean to minimize the seriousness of a PCa diagnosis without metastasis. I am simply saying that PCa can grow slowly and not cause real health issues for years until the cancer metastasizes.
If you have been diagnosed with PCa, regardless if you are “watching and waiting” or if you are considering more aggressive therapy such as radiation or a prostatectomy, consider supplementing with curcumin.
The study cited below offers reasons to supplement with the non-toxic, antioxidant called curcumin-
I am both a cancer survivor and cancer coach. I attribute my long-term CR from my “incurable” cancer, in part, to my supplementation with various evidence-based, non-toxic therapies such as curcumin. I supplement with and recommend a bioavailable formula called Life Extension Super Bio-Curcumin.
If you have any questions about your prostate cancer please scroll down the page, post a question or comment and I will reply to you ASAP.
“A new study led by a research team at Ludwig-Maximilians-Universität (LMU) in Munich now shows that it can also inhibit formation of metastases…Prostate cancer is one of the most prevalent malignancies in the Western world, and is often diagnosed only after metastatic tumors have formed in other organs...Curcumin is well tolerated and is therefore, in principle, suitable both for prophylactic use (primary prevention) and also for the suppression of metastases in cases where an established tumor is already present (secondary prevention)…Men with benign hyperplasia of the prostate (BHP) are one possible target group for prophylaxis, as are women who have a family history of breast cancer. The agent might also be valuable as a supplement to certain cancer therapies.
“Curcumin, an active component of the Indian curry spice turmeric, may help slow down tumor growth in castration-resistant prostate cancer patients on androgen deprivation therapy (ADT), a study from researchers at Jefferson’s Kimmel Cancer Center suggests…”
“This study sets the stage for further development of curcumin as a novel agent to target androgen receptor signaling,” said Dr. Knudsen. “It also has implications beyond prostate cancer since p300 and CBP are important in other malignancies, like breast cancer. In tumors where these play an important function, curcumin may prove to be a promising therapeutic agent.”